Do you or your loved one have Alzheimer’s disease?
If you, or a loved one, have been diagnosed with Alzheimer’s disease, you may be eligible for a study that will look at the safety and effectiveness of a possible new drug for treating Alzheimer’s disease. Participants must be between 50 to 80 years of age, and have a reliable caregiver. Additional criteria will be required for participation.
Eligible participants will receive:
• Potential access to a study drug at no charge
• Opportunity to participate in an open-label period during which all participants will receive the study drug
• Study-related support and monitoring by a healthcare team
• Education about Alzheimer’s disease
To see if you are eligible to participate in this study, contact Meridien Research at 407-644-1165